On July 1, Pacira (PCRX) sold its iovera franchise to Zimmer Biomet (ZBH) in a deal worth up to $140M to sharpen its focus on biopharmaceutical growth. On July 2, U.S. Physical Therapy purchased a majority stake in a physical therapy practice. Additionally, Orthofix Medical shares rose following a decision by the Centers for Medicare & Medicaid Services (CMS) to reverse its stance on non-invasive bone growth stimulators.
Orthofix Medical shares surged after the Centers for Medicare & Medicaid Services (CMS) reversed its restrictive stance on non-invasive bone growth stimulators.
Read the full storyThe company acquired a majority interest in a physical therapy practice as part of its ongoing strategy to expand its outpatient clinic footprint.
In a strategic move to refocus on biopharmaceuticals, Pacira (PCRX) sells its iovera franchise to Zimmer Biomet (ZBH) in a deal valued at up to $140 million.